| 2025-04-17 | -72.8% | news | Stock Titan | Latest AWHL News - Aspira Women's Health (OTCQB:AWHL) Enters K... - Stock Titan |
| 2025-04-16 | -64.6% | news | Seeking Alpha | Aspira Women's Health falls after receiving delisting notification from Nasdaq |
| 2025-04-16 | -64.6% | news | Stock Titan | Nasdaq Delists Aspira Women's Health: Key Facts About the OTC Markets Transition - Stock Titan |
| 2025-09-04 | +63.7% | executive | Seeking Alpha | Aspira Womens Health appoints Brian Hungerford as new CFO |
| 2024-07-11 | +36.7% | earnings | Seeking Alpha | Aspira Women's Health reports Q2 OvaSuite product volume |
| 2024-07-01 | -31.8% | news | Seeking Alpha | Aspira Womens Health announces $1.935M private placement equity financing |
| 2024-01-25 | +27.7% | news | Seeking Alpha | Aspira Womens Health announces $5.5M registered direct offering |
| 2026-04-06 | -22.7% | executive | GlobeNewswire | The Oncology Institute Names Minh Merchant Chief Legal Officer |
| 2023-09-13 | +21.0% | executive | Seeking Alpha | Aspira Women's Health CFO buys 2,246 shares in the company |
| 2023-09-13 | +21.0% | news | Seeking Alpha | Aspira WomensHealthregains Nasdaq compliance |
| 2023-11-13 | -18.5% | earnings | Seeking Alpha | Aspira Womens Health GAAP EPS of -$0.48 beats by $0.03, revenue of $2.22M misses by $0.68M |
| 2023-08-15 | -14.7% | earnings | Seeking Alpha | Aspira Women's Health Inc. (AWH) Q2 2023 Earnings Call Transcript |
| 2024-03-28 | -12.6% | earnings | Seeking Alpha | Aspira Womens Health GAAP EPS of -$0.30 beats by $0.15, revenue of $2.13M misses by $0.42M |
| 2024-03-28 | -12.6% | earnings | Seeking Alpha | Aspira Women's Health Inc. (AWH) Q4 2023 Earnings Call Transcript |
| 2025-03-27 | +12.3% | earnings | Seeking Alpha | Aspira Womens Health GAAP EPS of -$0.08, revenue of $2.34M misses by $0.66M |
| 2025-05-19 | -12.3% | earnings | Seeking Alpha | Aspira Womens Health GAAP EPS of -$0.09, revenue of $2.28M |
| 2023-08-09 | +10.3% | executive | Seeking Alpha | Aspira Womens Health COO to step down |
| 2024-05-15 | -10.0% | earnings | Seeking Alpha | Aspira Women's Health Inc. (AWH) Q1 2024 Earnings Call Transcript |
| 2024-05-15 | -10.0% | earnings | Seeking Alpha | Aspira Womens Health GAAP EPS of -$0.39 misses by $0.06, revenue of $2.15M misses by $0.43M |
| 2026-03-26 | +9.5% | expansion | Minichart | Aspira Women’s Health Inc. Announces Mayo Clinic Laboratories Agreement for Ova1Plus and OvaWatch Tests – SEC 8-K Filing December 2025 - Minichart |
| 2025-08-13 | +8.7% | earnings | Seeking Alpha | Aspira Womens Health GAAP EPS of -$0.07, revenue of $2.4M |
| 2024-07-17 | -7.5% | news | Seeking Alpha | Aspira Women's Health files to sell 2.5M shares of common stock for holders |
| 2023-12-07 | +7.2% | executive | Seeking Alpha | Aspira Women's Health CEO Nicole Sandford discloses purchase of over 5K shares |
| 2024-11-14 | -6.6% | earnings | Seeking Alpha | Aspira Women's Health Inc. (AWH) Q3 2024 Earnings Call Transcript |
| 2024-11-14 | -6.6% | earnings | Seeking Alpha | Aspira Womens Health reports Q3 results |
| 2024-08-12 | -6.1% | earnings | Seeking Alpha | Aspira Womens Health GAAP EPS of -$0.28 beats by $0.02, revenue of $2.4M misses by $0.2M |
| 2024-04-22 | -5.0% | legal | Seeking Alpha | Aspira Women's Health files for $100M mixed securities shelf |
| 2023-08-14 | -4.3% | earnings | Seeking Alpha | Aspira Womens Health GAAP EPS of -$0.28 beats by $0.27, revenue of $2.5M misses by $0.3M |
| 2024-04-05 | +3.3% | news | Seeking Alpha | Aspira Women's Health files to sell 1.57M shares for holders |
| 2023-11-14 | -3.2% | earnings | Seeking Alpha | Aspira Women's Health Inc. (AWH) Q3 2023 Earnings Call Transcript |
| 2024-08-13 | -2.0% | earnings | Seeking Alpha | Aspira Women's Health Inc. (AWH) Q2 2024 Earnings Call Transcript |
| 2025-09-18 | +1.7% | news | Seeking Alpha | Aspira Women's Health raises over $3M privately |
| 2025-09-18 | +1.7% | news | Investing.com | Aspira Women’s Health raises $3.06 million through equity financing - Investing.com |
| 2025-11-14 | +0.9% | earnings | Seeking Alpha | Aspira Womens Health GAAP EPS of -$0.13, revenue of $2.31M |
| 2026-04-01 | -0.8% | earnings | Associated Press | Aspira: Q4 Earnings Snapshot |
| 2026-04-01 | -0.8% | news | TipRanks | Aspira Women’s Health Delays Annual 10-K Filing - TipRanks |
| 2026-03-31 | -0.7% | news | marketscreener.com | Aspira Women's Health Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com |
| 2026-04-23 | -0.4% | news | ACCESS Newswire | Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) |
| 2024-12-16 | -0.0% | executive | Seeking Alpha | Aspira Womens Health appoints Sandra Milligan as interim CEO as Sandford departs |
| 2026-04-26 | — | news | MSN | Aspira Women's Health raises over $3M privately - MSN |
| 2026-04-25 | — | news | TradingView | Net current asset value per share of Aspira Women's Health Inc. – OTC:AWHL - TradingView |
| 2026-04-24 | — | news | The Batesville Daily Guard | Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) - The Batesville Daily Guard |